Expert
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is the market bouncing already? Buy the dip sell the rip.
Of course the market bounces up and down.
AEI
All markets have bounces up and down. Really day traders like me love the volatility. And you need to calm down and remember its only money.
AEI My charts show Support at .476 .452 .397. 50 DMA according to my charts is right at .473 and it has bounced off support several times. What you think?
One more note. I was not talking about this market bouncing to 'new highs' I was clearly talking about it bouncing.
Nobody knows what the market will do until it does it. Sometimes people are right and sometime they are wrong. Many people only remember when they are right and we call them the experts. LOL.
Friday March 11th markets dipped like this than Monday 14th they dipped lower and than on Tuesday started to skyrocket. Be nice if it followed that pattern again. Everybody was so negative than too of course. If this is followed by another big dip Monday I will load half my cash Monday afternoon.
Looked interesting but few interested.
WINT New all time lows today after big move up on news. Wonder if anybody shorted on that move up maybe cover today. Tough market but you have to buy when they sell and sell when they are buying. Buy the fear sell the greed. Buy the dip sell the rip. How many more cliches do we need?
WINT Should bounce back over $1 today or tomorrow.
WINT @.89 New all time low after big move up yesterday. Just got some .9 will continue to load if it continues to drop. Figure same people who bought 1.43 yesterday are selling today. Crazy.
TLSA Straddle worked perfect. Big move.
Plan on loading. Markets should be up tomorrow on TSLA earnings.
AEI .4911 in afters.
I straddled TSLA hope for big move either way. Probably be a flat line. LOL.
WINT Crashed from 1.43 all the way to .97 red. Crazy on high volume. Higher than that in PM
Same here. I look for them in afters.
STSS Crashing in afters.
Not fun sending all that money to the Government. I do not mind paying taxes just does not seem like I am getting a good return back from them. Just wanted to gripe a little to some folks that might understand. Now lets make more money.
WORX
NMTR 8-k Just out about license agreement with European Biomedical Research institute of Salerno (EBRIS). Looks like it has not been released in pr. Anybody see a pr for this?
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001551986/000155198622000034/nmtr-20220411.htm
ENVB .30 Low Cap bio. Getting volume.
They just announced offering a few weeks ago Preferred shares that convert at $1.50 and warrants at $2.
GFAI Offering closed. Guess that means it will run.
https://finance.yahoo.com/news/guardforce-ai-announces-closing-10-200000271.html
ANY Debt financing not equity financing. Eom
ACRX AcelRx was trading around $3.00 per share prior to the FDA Warning Letter issued in February 2021. Why they released this good news in an 8-k instead of pr. Oh well.
Item 8.01 Other Events
As previously disclosed, on February 11, 2021, AcelRx Pharmaceuticals, Inc. (the “Company”) received a warning letter from the Office of Prescription Drug Promotion (“OPDP”) of the U.S. Food and Drug Administration (the “FDA”) (the “Warning Letter”) relating to certain promotional materials used by the Company in 2019.
On March 28, 2022, the Company received a Warning Letter close-out letter (“close-out letter”) from the OPDP indicating that the FDA has concluded its evaluation of the Company’s corrective actions in response to the Warning Letter and that the Company has addressed the issues raised by the Warning Letter.
https://www.sec.gov/Archives/edgar/data/0001427925/000143774922007847/acrx20220331_8k.htm
ACRX Interesting 8-k just out. They released news on a study but not the info in the 8-k. The 8-k is the news they should have released.
Item 8.01 Other Events
As previously disclosed, on February 11, 2021, AcelRx Pharmaceuticals, Inc. (the “Company”) received a warning letter from the Office of Prescription Drug Promotion (“OPDP”) of the U.S. Food and Drug Administration (the “FDA”) (the “Warning Letter”) relating to certain promotional materials used by the Company in 2019.
On March 28, 2022, the Company received a Warning Letter close-out letter (“close-out letter”) from the OPDP indicating that the FDA has concluded its evaluation of the Company’s corrective actions in response to the Warning Letter and that the Company has addressed the issues raised by the Warning Letter.
https://www.sec.gov/Archives/edgar/data/0001427925/000143774922007847/acrx20220331_8k.htm
ADMG Change of Control 8-k out. 3.5 million float.
https://www.otcmarkets.com/filing/html?id=15699987&guid=s26wknwhj2AMQth
TMBR @.41 initiated at $2 by HC Wainwright & Co.
3/31/2022 TMBR Timber Pharmaceuticals Initiates Coverage On HC Wainwright & Co.
https://www.benzinga.com/quote/TMBR/analyst-ratings
MTC @.61 Low float China stock that has not ran yet.
ACRX @.28 all time low. No bad news out today.
TRKA Seems like it should be a lot higher with all the news and low float. Guess it will run at some point.
https://finance.yahoo.com/news/troika-media-group-completes-transformative-120000605.html
ANPC @.46 Lowest market cap China stock that hasn't really ran yet plus news updates at any time.
https://finance.yahoo.com/news/anpac-bio-bio-chip-subsidiary-120000841.html
SYN Update to their trial drug is due anytime now.
SYN Is there a new target or the one from Maxim last year?
NBY Low market cap compared to other runners with lots of good news surprised it has not ran yet. Will at some point.
https://finance.yahoo.com/quote/NBY/?p=NBY
NBY .28 Has not ran yet.
TRKA @ 1.04 after hours. Down .18 today.
HCTI EF Hutton initiates at $4.Low Float. Got a few. Needs volume.
https://www.benzinga.com/quote/HCTI/analyst-ratings